Noscira Initiates Phase II Clinical Trials With NP 12, Its First Drug For Alzheimer’s Disease

Noscira, a company of Zeltia group devoted to the research and development of innovative drugs for the treatment of diseases of the nervous system, has received the approval of the Austrian health authorities and the Ethics Committee for the initiation of the first Phase II study with NP-12 for the treatment of Alzheimer’s disease. NP-12, the first compound of Noscira’s product pipeline, is an innovative drug of a new family of compounds.

More: continued here

Comments are closed.



Free prescriptions rx - : Free prescriptions rx
Pharmacy Brand Name - Buy Brandname Drugs: Depending on your prescription needs, your savings could be significant if you order online.
Pills Store Online - Buy Drugs: Pills sotre online
Pills 2 Me - Order RX Pills for You: Just select the medicines you need, fill in our medical questionnaire, and submit your order.
RX Hint - Information and products: Find more details about Rx products only by entering.
Rx pharma online - : Rx pharma online
Drug any time - : Drug any time
Latest News...